Oldenburg J - Search Results

1

Testicular cancer in 2013: towards personalized medicine--are we there yet?

Oldenburg J, Fosså SD. Oldenburg J, et al. Nat Rev Urol. 2014 Feb;11(2):68-9. doi: 10.1038/nrurol.2013.298. Epub 2013 Dec 24. Nat Rev Urol. 2014. PMID: 24366345

2

Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.

Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Oldenburg J, et al. J Clin Oncol. 2003 Sep 1;21(17):3310-7. doi: 10.1200/JCO.2003.03.184. J Clin Oncol. 2003. PMID: 12947067

3

Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors.

Oldenburg J, Fosså SD, Dahl AA. Oldenburg J, et al. Qual Life Res. 2006 Jun;15(5):791-800. doi: 10.1007/s11136-005-5370-6. Qual Life Res. 2006. PMID: 16721639

4

Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study.

Oldenburg J, Kraggerud SM, Brydøy M, Cvancarova M, Lothe RA, Fossa SD. Oldenburg J, et al. J Transl Med. 2007 Dec 27;5:70. doi: 10.1186/1479-5876-5-70. J Transl Med. 2007. PMID: 18162130 Free PMC article.

5

[Testicular cancer].

Oldenburg J, Lehne G, Fosså SD. Oldenburg J, et al. Tidsskr Nor Laegeforen. 2008 Feb 14;128(4):457-60. Tidsskr Nor Laegeforen. 2008. PMID: 18274581 Free article. Review. Norwegian.

6

Late relapse of germ cell tumors.

Oldenburg J, Wahlqvist R, Fosså SD. Oldenburg J, et al. World J Urol. 2009 Aug;27(4):493-500. doi: 10.1007/s00345-009-0411-3. Epub 2009 Apr 17. World J Urol. 2009. PMID: 19373473 Review.

7

Short- and long-term morbidity after treatment for testicular cancer.

Fosså SD, Oldenburg J, Dahl AA. Fosså SD, et al. Among authors: oldenburg j. BJU Int. 2009 Nov;104(9 Pt B):1418-22. doi: 10.1111/j.1464-410X.2009.08869.x. BJU Int. 2009. PMID: 19840023 Review.

8

Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Brydøy M, Oldenburg J, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Hauge ER, Dahl O, Fosså SD. Brydøy M, et al. Among authors: oldenburg j. J Natl Cancer Inst. 2009 Dec 16;101(24):1682-95. doi: 10.1093/jnci/djp413. J Natl Cancer Inst. 2009. PMID: 19940282 Free PMC article.

9

Testicular cancer survivorship: research strategies and recommendations.

Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen FE, Williams JP, Nichols CR, Einhorn LH, Fossa SD. Travis LB, et al. Among authors: oldenburg j. J Natl Cancer Inst. 2010 Aug 4;102(15):1114-30. doi: 10.1093/jnci/djq216. Epub 2010 Jun 28. J Natl Cancer Inst. 2010. PMID: 20585105 Free PMC article. Review.

10

Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients.

Fosså SD, Cvancarova M, Chen L, Allan AL, Oldenburg J, Peterson DR, Travis LB. Fosså SD, et al. Among authors: oldenburg j. J Clin Oncol. 2011 Mar 10;29(8):963-70. doi: 10.1200/JCO.2010.32.3204. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

762 results

Search Page